-transparent.png){kind=logo}
The pharmacokinetic profile of ketoprofen suppositories following single and chronic (32 doses) administration to 12 healthy adult male volunteers was established. Each subject received a single rectal dose of 100 mg of ketoprofen on day 1, followed by one suppository of 100 mg b.i.d. for days 8--22, and finally one suppository on day 23. Plasma samples were analysed by gas-liquid chromatography. Following single doses, the mean maximum observed concentrations of ketoprofen in plasma (6.56 microgram ml-1) were achieved at 1.1 h; the mean elimination half-life was 1.78 h. The results indicate that ketoprofen is rapidly and reproducibly absorbed and eliminated from the suppository dose form.
G Caillé, and
J G Besner, and
Y Lacasse, and
M Vézina
January 1976,
Rheumatology and rehabilitation,
G Caillé, and
J G Besner, and
Y Lacasse, and
M Vézina
January 1976,
Rheumatology and rehabilitation,
G Caillé, and
J G Besner, and
Y Lacasse, and
M Vézina
January 1991,
Pharmacotherapy,
G Caillé, and
J G Besner, and
Y Lacasse, and
M Vézina
January 1985,
Current medical research and opinion,
G Caillé, and
J G Besner, and
Y Lacasse, and
M Vézina
October 1978,
Il Farmaco; edizione pratica,
G Caillé, and
J G Besner, and
Y Lacasse, and
M Vézina
November 1986,
Zhongguo yao li xue bao = Acta pharmacologica Sinica,
G Caillé, and
J G Besner, and
Y Lacasse, and
M Vézina
February 1990,
Journal of clinical pharmacy and therapeutics,
G Caillé, and
J G Besner, and
Y Lacasse, and
M Vézina
October 1956,
Dansk tidsskrift for farmaci,
G Caillé, and
J G Besner, and
Y Lacasse, and
M Vézina
December 1983,
La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
G Caillé, and
J G Besner, and
Y Lacasse, and
M Vézina
January 2022,
Journal of veterinary pharmacology and therapeutics,
